|
1
|
Hafstad AD, Nabeebaccus AA and Shah AM:
Novel aspects of ROS signalling in heart failure. Basic Res
Cardiol. 108:3592013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J and Martin JF: Macro advances in
microRNAs and myocardial regeneration. Curr Opin Cardiol.
29:207–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sala V, Bergerone S, Gatti S, Gallo S,
Ponzetto A, Ponzetto C and Crepaldi T: MicroRNAs in myocardial
ischemia: Identifying new targets and tools for treating heart
disease. New frontiers for miR-medicine. Cell Mol Life Sci.
71:1439–1452. 2014. View Article : Google Scholar
|
|
4
|
Port JD and Sucharov C: Role of microRNAs
in cardiovascular disease: Therapeutic challenges and potentials. J
Cardiovasc Pharmacol. 56:444–453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xia W, Ma X, Li X, Dong H, Yi J, Zeng W
and Yang Z: miR-153 inhibits epithelial-to-mesenchymal transition
in hepatocellular carcinoma by targeting Snail. Oncol Rep.
34:655–662. 2015.PubMed/NCBI
|
|
6
|
Zhou J, Xie M, Shi Y, Luo B, Gong G, Li J,
Wang J, Zhao W, Zi Y, Wu X and Wen J: MicroRNA-153 functions as a
tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer
cells. Oncol Rep. 34:111–120. 2015.PubMed/NCBI
|
|
7
|
Hua HW, Jiang F, Huang Q, Liao Z and Ding
G: MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular
carcinoma through suppression of WWOX. Oncotarget. 6:3840–3847.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shan N, Shen L, Wang J, He D and Duan C:
MiR-153 inhibits migration and invasion of human non-small-cell
lung cancer by targeting ADAM19. Biochem Biophys Res Commun.
456:385–391. 2015. View Article : Google Scholar
|
|
9
|
Carroll RG, Hollville E and Martin SJ:
Parkin sensitizes toward apoptosis induced by mitochondrial
depolarization through promoting degradation of Mcl-1. Cell Rep.
9:1538–1553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thomas RL, Roberts DJ, Kubli DA, Lee Y,
Quinsay MN, Owens JB, Fischer KM, Sussman MA, Miyamoto S and
Gustafsson ÅB: Loss of MCL-1 leads to impaired autophagy and rapid
development of heart failure. Genes Dev. 27:1365–1377. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jokinen E and Koivunen JP: Bcl-xl and
Mcl-1 are the major determinants of the apoptotic response to dual
PI3K and MEK blockage. Int J Oncol. 47:1103–1110. 2015.PubMed/NCBI
|
|
12
|
Cerella C, Muller F, Gaigneaux A, Radogna
F, Viry E, Chateauvieux S, Dicato M and Diederich M: Early
downregulation of Mcl-1 regulates apoptosis triggered by cardiac
glycoside UNBS1450. Cell Death Dis. 6:e17822015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Varadarajan S, Poornima P, Milani M, Gowda
K, Amin S, Wang HG and Cohen GM: Maritoclax and dinaciclib inhibit
MCL-1 activity and induce apoptosis in both a MCL-1-dependent and
-independent manner. Oncotarget. 6:12668–12681. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Bathina M, Lynch J, Koss B,
Calabrese C, Frase S, Schuetz JD, Rehg JE and Opferman JT: Deletion
of MCL-1 causes lethal cardiac failure and mitochondrial
dysfunction. Genes Dev. 27:1351–1364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Xu J, He L, Peng L, Zhong Q, Chen L
and Jiang Z: The role of autophagy in cardiac hypertrophy. Acta
Biochim Biophys Sin. 2016.
|
|
16
|
Jia Z, Liu Y, Su H, Li M, Zhang M, Zhu Y,
Li T, Fang Y and Liang S: Safflower extract inhibiting apoptosis by
inducing autophagy in myocardium derived H9C2 cell. Int J Clin Exp
Med. 8:20254–20262. 2015.
|
|
17
|
Schiattarella GG and Hill JA: Therapeutic
targeting of autophagy in cardiovascular disease. J Mol Cell
Cardiol. 2015.PubMed/NCBI
|
|
18
|
Wang K, Liu F, Zhou LY, Ding SL, Long B,
Liu CY, Sun T, Fan YY, Sun L and Li PF: miR-874 regulates
myocardial necrosis by targeting caspase-8. Cell Death Dis.
4:e7092013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Liao X and Wong C: Downregulations
of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by
microRNA 153 induce apoptosis in a glioblastoma cell line
DBTRG-05MG. Int J Cancer. 126:1029–1035. 2010.
|
|
20
|
Wang K, Liu CY, Zhang XJ, Feng C, Zhou LY,
Zhao Y and Li PF: miR-361-regulated prohibitin inhibits
mitochondrial fission and apoptosis and protects heart from
ischemia injury. Cell Death Differ. 22:1058–1068. 2015. View Article : Google Scholar :
|
|
21
|
Xu C, Hu Y, Hou L, Ju J, Li X, Du N, Guan
X, Liu Z, Zhang T, Qin W, et al: β-Blocker carvedilol protects
cardiomyocytes against oxidative stress-induced apoptosis by
up-regulating miR-133 expression. J Mol Cell Cardiol. 75:111–121.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bai Z, Sun J, Wang X, Wang H, Pei H and
Zhang Z: MicroRNA-153 is a prognostic marker and inhibits cell
migration and invasion by targeting SNAI1 in human pancreatic
ductal adenocarcinoma. Oncol Rep. 34:595–602. 2015.PubMed/NCBI
|
|
23
|
Nakai A, Yamaguchi O, Takeda T, Higuchi Y,
Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, et
al: The role of autophagy in cardiomyocytes in the basal state and
in response to hemodynamic stress. Nat Med. 13:619–624. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dutta D, Xu J, Kim JS, Dunn WA Jr and
Leeuwenburgh C: Upregulated autophagy protects cardiomyocytes from
oxidative stress-induced toxicity. Autophagy. 9:328–344. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang JX, Jiao JQ, Li Q, Long B, Wang K,
Liu JP, Li YR and Li PF: miR-499 regulates mitochondrial dynamics
by targeting calcineurin and dynamin-related protein-1. Nat Med.
17:71–78. 2011. View
Article : Google Scholar
|
|
26
|
Zhao Y, Samal E and Srivastava D: Serum
response factor regulates a muscle-specific microRNA that targets
Hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
